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Abstract 
Introduction: Debridement, antibiotics and implant retention (DAIR) is known to be effective in 
treating acute periprosthetic joint infection (PJI). However, deciding to perform additional surgery 
in the early postoperative period may be challenging as there is the concern of adding morbidity and 
clinical presentation is often subtle. We mean to assess the impact of early DAIR on final functional 
outcome. 
Methods: A case-control comparison was performed between patients that underwent DAIR for 
suspected PJI between 2010-2016 and controls randomly selected (1:2 ratio) from a list of primary 
joint replacements. Patients were matched for anatomic site, age, gender, American Society of 
Anesthesiologists (ASA) classification, body mass index and follow-up time. The outcome of surgical 
treatment and complications were assessed and Hip disability and Osteoarthritis Outcome Score 
(HOOS) or Knee injury and Osteoarthritis Outcome Score (KOOS) were performed. 
Results: Thirty-eight cases were included at a mean follow-up of 42 months. Infection was not 
confirmed in one patient. There was one infection related-death and three other cases of treatment 
failure that required a two-stage revision. Overall success rate was 89.2%. There were no significant 
patient reported differences regarding final functional outcome between both groups: pain 91±6 vs. 
87±13; other symptoms 90±8 vs. 90±9; activities of day living 86±8 vs. 85±14; sport 63±13 vs. 
57±16; quality of life 78±17 vs. 76±16.  
Discussion: These findings support that DAIR for suspected acute PJI is safe, effective and causes 
no impact on final functional results. Thus, a low threshold for assuming infection and subsequent 
DAIR may safely be adopted in the early postoperative period. 
Key words: acute prosthetic join infection; antibiotics; debridement; irrigation; retention; functional outcome 
Introduction 
Prosthetic joint infection (PJI) is one of the most 
dramatic complications after a total joint replacement 
with potential devastating long-term physical and 
psychological consequences, leading to significant 
impairment in the quality of life. In adition, it is 
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associated with increased costs and burden to the 
healthcare system (1).  
Debridement, antibiotics and irrigation with 
implant retention (DAIR) is an appealing treatment 
alternative especially for acute PJI where it seems to 
offer the best results (2). However, diagnosing early 
infection can be challenging and deciding to perform 
additional surgeries in the early postoperative is not 
always easy as the risk/benefit ratio of further 
surgery is not always clear. If clinical presentation is 
clear (e.g. fever, purulent drainage, etc.) no one will 
doubt to go ahead with DAIR but often clinical 
presentation of early PJI is much more subtle and the 
fear of adding morbidity may delay or even preclude 
the decision. 
Persistent wound drainage is a known risk factor 
for infection (3, 4) but what exactly constitutes 
abnormal wound drainage is a matter of debate and 
recommendations on the correct way to manage it 
vary considerably. To further intricate decision- 
making, surgeons often face the inherently complex 
and also controversial issue of differentiating 
superficial infection requiring superficial wound 
washout or perhaps antibiotic therapy only from deep 
surgical site infection requiring a formal DAIR 
procedure (5). 
The goal of this study is to evaluate an 
institutional policy of “aggressively” pursuing DAIR 
in the early postoperative period with respect to its 
accuracy in identifying deep surgical site infection, its 
effectiveness and safety profile and most importantly 
to evaluate its impact on final functional outcomes. 
Methods 
Patient selection 
This is a retrospective case-control study at a 
single institution. We included all patients that 
underwent DAIR with modular parts exchange for 
suspected acute postoperative infection of total hip or 
knee arthroplasty between 2010-2016. Our current 
institutional recommendation is to perform a formal 
DAIR in the early postoperative period if: 1) persistent 
wound drainage and C-reactive protein (CRP) rising 
trend after the initial 72 hours; 2) persistent wound 
drainage by day 10 regardless of CRP measurements; 
3) strong clinical suspicion such as significant wound 
healing disturbance (i.e. “superficial” wound 
infection, “superficial” skin necrosis or wound 
dehiscence) is present at any time in the early weeks 
postoperatively regardless of CRP measurements. 
Controls were randomly selected (1:2 ratio) from 
a list of primary arthroplasty patients in the same time 
period matching for anatomic site, age, gender, 
American Society of Anesthesiologists (ASA) 
classification, Body Mass Index (BMI) and follow-up 
time. 
Surgical Treatment Protocol 
All patients with suspected acute PJI underwent 
a formal DAIR with systematic and thorough 
debridement with mobile parts exchange. The first 
step is to reopen the wound and clean any 
subcutaneous fluids and clots. If the deep fascia is 
found to be closed, then superficial debridement is 
performed, collecting separate tissue samples for 
microbiological study. When this layer is 
macroscopically clean, synovial fluid is collected with 
a needle, in order to obtain a sample of 
uncontaminated synovial fluid, and then the deep 
fascia is open with a new set of instruments. After 
arthrotomy, the mobile components are removed in 
order to increase access and allow better cleansing of 
all prosthetic interfaces. A thorough and meticulous 
debridement of all devitalized tissues and extensive 
synovectomy are performed. At this stage, a 
minimum of five tissue samples are systematically 
obtained and sent to microbiological study, preferably 
choosing macroscopically purulent tissues and/or 
tissues in intimate contact with the prosthesis. After 
thorough excision of suspicious tissues and removal 
of all the suture material, copious irrigation is 
performed. Three liters of chlorhexidine gluconate 
scrub are used initially, followed by another three 
liters of saline solution. After this step, the wound is 
temporarily involved in sterile compress dressing and 
the surgical team change gloves and protective 
clothing and a new set of sterile surgical tools are 
presented. An additional 1 L of saline irrigation is 
performed prior to the replacement of new mobile 
components to replace those that have been removed. 
In all cases a drain is used. The wound is closed in 
layers as tightly as possible using a technique similar 
to primary surgery (absorbable suture in the deep 
fascia and staples in the skin). No local antibiotics 
were used. 
Medical Treatment Protocol 
When facing a persistent wound drainage or 
unfavorable wound healing, we do not initiate 
antibiotic therapy. Serial CRP measurements are 
performed daily and nonoperative measures such as 
modification of venous thromboembolism 
prophylaxis, nutritional supplementation, dressing 
modification and restriction of range of motion are 
taken. 
As described earlier, if CRP shows a rising trend 
after the initial 72 hours, there is persistent wound 
drainage after day 10 or a strong clinical suspicion 
arises a decision to go ahead with surgery is taken. 
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After surgery and microbiology samples are 
gathered, broad spectrum intravenous antibiotics are 
initiated (i.e. vancomycin and piperacillin/ 
tazobactam in accordance with our local microbial 
flora antibiotic susceptibility patterns). 
As soon as definitive microbiology results are 
available, antibiotic therapy is deescalated according 
to isolated pathogens(s) and antibiotic susceptibility 
patterns. Every case was considered on an individual 
basis and in a multidisciplinary consultation with an 
infectious diseases specialist. Switch from intravenous 
to oral regimens is not dependent on any previously 
established time, but a combination of good clinical 
response with and the possibility of antibiotic(s) with 
good oral bioavailability. Antibiotic therapy was 
usually extended for at least three months. Whenever 
possible an “anti-biofilm” antibiotic combination, 
including rifampicin for staphylococci and 
ciprofloxacin for Gram-negative infections, was used. 
PJI definition, Follow-up and Outcome 
Given the paucity of evidence regarding acute 
PJI definition we chose to define PJI exclusively based 
on the positivity of at least one deep (subfascial) 
sample collected intra-operatively either synovial 
fluid or periprosthetic tissue.  
After hospital discharge, all patients were 
routinely followed up in clinic at about three and six 
weeks, three, six and twelve months and then 
annually.  
A 2-year minimum follow-up after antibiotic 
therapy discontinuation was considered, as most 
failures occur during this time period (6, 7). Infection 
was deemed to be cured when the wound healed 
uneventfully with no signs or symptoms of infection, 
the joint was pain free and serum inflammatory 
parameters gradually decreased and were persistently 
low despite antibiotic discontinuation. Diagnoses of a 
chronic infection or the need for subsequent surgery 
were considered treatment failures. Medical-surgical 
complications and re-operation rates were recorded. 
Functional outcome was assessed using joint 
specific patient-reported outcome measures: Hip 
disability and Osteoarthritis Outcome Score (HOOS) 
or Knee injury and Osteoarthritis Outcome Score 
(KOOS). HOOS and KOOS scores are a patient- 
reported outcome measurement instrument, develop-
ed to assess the patient’s opinion about their hip and 
knee and associated problems, respectively. The 
HOOS is composed of 40 questions and looks at five 
subscales: Pain (10 items), Symptoms (5 items), 
Activity of Daily Living (17 items), Sport and 
Recreation Function (4 items) and Hip-Related 
Quality of Life (4 items). The KOOS evaluates both 
short-term and long-term consequences of knee 
injury. It holds 42 items in five separately scored 
subscales: Pain, Symptoms, Function in Daily Living, 
Function in Sport and Recreation (Sport/Rec), and 
Knee-related Quality of Life (QOL). In both cases, a 
total score is calculated by using a simple formula to 
produce a score that ranges from 0-100, with zero 
representing extreme hip or knee problems and 100 
representing no problems.  
Statistical Analysis 
All the statistical analysis was performed by 
SPSS 25.0 software. Univariate analysis was 
conducted to assess differences of patients-related 
data and functional scores between cases and 
controls. Independent samples t-tests for continuous 
data and Chi-square tests for dichotomous data were 
performed. P values <0.05 were considered as 
statistically significant. 
Results 
A total of 2503 primary hip or knee 
arthroplasties were performed during this period. 
Thirty-nine patients with suspected acute 
postoperative total hip or knee arthroplasty infection 
were submitted to DAIR: 4 patients with isolated 
persistent drainage by day-10, 24 patients with CRP 
rising trend after initial 72 hours and simultaneously 
persistent wound drainage or wound healing 
disturbance and in 11 patients we found strong 
clinical suspicion as superficial wound infection or 
wound dehiscence. The primary arthroplasties and 
DAIR procedures were performed by six surgeons 
and the DAIR was not always performed by the same 
initial operating surgeon. Mean time from primary 
joint replacement to DAIR was 22.6 (6-30) days and 
mean follow-up time was 42.1 (24-66) months.  
A mean of two superficial and two deep tissue 
samples as well as one synovial fluid sample were 
collected. Infection was confirmed postoperatively, 
with most patients showing multiple positive samples 
and only one case with a single deep positive sample 
in final microbiology results. Only one patient had no 
positive cultures and, in this case, antibiotic therapy 
was interrupted as soon as definitive microbiology 
results were available. 
After surgery, broad spectrum intravenous 
antibiotics were initiated and then deescalated as soon 
as definitive microbiology results were available. A 
mean total antibiotic therapy time of 3.2 (3-4.1) 
months was found. 
DAIR successfully eradicated infection in 34 out 
of 38 patients (89.5%). No adverse events due to the 
antibiotics were found. There was one infection- 
related death occurring as the consequence of a multi- 
organ failure in the early postoperative period, 3 
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weeks after a THA, despite surgical treatment and 
broad-spectrum antibiotics. This was an 83 years-old 
patient with major comorbidities (i.e. ASA 3, diabetes 
mellitus and Child B liver failure) in which an 
enterococcus faecium was isolated. Three other cases 
progressed to chronic infection requiring subsequent 
two-stage revision. In these cases, mean time from 
arthroplasty to DAIR was 24 (23-28) days and mean 
time for failure was nine weeks. One 
methicillin-resistant Staphylococcus aureus, one 
methicillin-sensitive Staphylococcus aureus, and one 
Staphylococcus epidermidis were isolated in each 
patient. The same antibiotic protocol was applied in 
these patients including rifampicin. No other major 
medical-surgical complications related to the 
procedure were noted. 
 
Table 1. Microorganisms isolated in 38 confirmed prosthetic joint 
infection cases 
Isolated microorganisms Overall (n=64) 
Gram positive 45 (70.3%) 
CoN staphylococci 21 (32.8%) 
Staphylococcus aureus 18 (28.1%) 
Other  
 Enterococcus spp. 3 (4.7%) 
 Streptococcus spp. 2 (3.1%) 
 Corynebacterium spp. 1 (1.6%) 
Gram negative 19 (29.7%) 
Enterobacteriaceae  
 Escherichia coli 7 (10.9%) 
 Serratia spp. 3 (4.7%) 
 Klebsiella spp. 1 (1.6%) 
 Proteus spp. 2 (3.1%) 
 Citrobacter spp. 1 (1.6%) 
Pseudomonas spp. 4 (6.2%) 
Others  
 Acinetobacter spp. 1 (1.6%) 
Polymicrobial 11 (17.2%) 
CoN – coagulase negative. 
 
 
Of those who achieved infection eradication, 26 
were available for functional evaluation (12 hips and 
14 knee patients). Reasons for exclusion of the 
functional outcome analysis were: two unrelated 
complications that preclude functional evaluation 
(one periprosthetic fracture and one contralateral 
amputation], three patient deaths from unrelated 
causes (all of them without evidence of infection 
relapse after at least two years follow-up) and three 
patients were lost to the follow-up. 
Fifty-two matched uneventful joint replacement 
patients were also assessed. Control group and 
patients with acute PJI did not differ with respect to 
joint, age, gender, ASA classification, BMI and mean 
follow-up time (Table 2).  
Patient self-reported functional outcomes after a 
2-year minimum follow-up, showed no significant 
differences between cases and controls in any 
category including pain and other symptoms, as 
quality of life (see Table 3). When evaluating the 
functional outcome by clinical presentation (persistent 
drainage vs. more obvious clinical findings) and by 
microorganism type (Staphylococcus aureus or even 
MRSA vs. other pathogens) no differences were 
found. 
 
Table 2. Demographic data of infected and control patients 
 Case (n=26) Controls (n=52) p 
Joint    .999 
 THA 12 24  
 TKA 14 28  
Age, years 68.9 69.2 .880 
Gender   .643 
 Female 16 32  
 Male 10 20  
ASA score   .999 
 ASA 1 0 0  
 ASA 2 21 42  
 ASA 3 5 10  
 ASA 4 0 0  
BMI 29.7 28.0 .070 
Follow-up, months 42.1 43.65 .541 
THA: total hip arthroplasty; TKA: total knee arthroplasty; ASA: American Society 
of Anesthesiologists; BMI: body mass index; DM: Diabetes Mellitus. 
 
Table 3. Final functional results (HOOS/KOOS) of infected and 
control patients 
 Case (n=26) Controls (n=52) P 
Pain 91.2±6.0 87.3±12.6 .141 
Other Symptoms 90.1±7.8 89.7±9.4 .844 
Activities of day living 85.9±7.7 85.2±14.1 .826 
Sports 62.65±13.3 56.5±16.4 .103 
Quality of life 78.3±17.0 76.1±15.8 .569 
KOOS - Knee injury and Osteoarthritis Outcome Score; HOOS – Hip Disability and 
Osteoarthritis Outcome Score. 
 
Discussion 
Debridement, antibiotics and irrigation with 
implant retention (DAIR) is commonly viewed as a 
first-line treatment alternative for acute postoperative 
PJI(2). Nevertheless, the decision to perform it in the 
early postoperative period is not always easy. Often, 
diagnosis of acute periprosthetic infection can be 
extremely difficult because clinical manifestations are 
not always obvious. Although acute PJI cases are 
sometimes obvious presenting fever and purulent 
discharge, they can also have subtle changes such as 
small wound dehiscence or prolonged wound 
discharge (8). Whether these minor changes are cause 
or consequence of infection is debatable but they are 
well established risk factors (3, 4). 
The optimal management of such unclear cases 
is also a matter of debate. A recent International 
Consensus Meeting (9) suggested that surgical 
intervention should be considered after five to seven 
days of persistent wound discharge despite 
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conservative measures. It was also suggested that the 
surgeon should rely on the status of the fascia to 
decide whether to simply perform a superficial 
irrigation and debridement and wound closure (if the 
fascia is judged to be intact) or proceed to modular 
components exchange if the fascia is not intact (9). 
In our department we shave been systematically 
using a uniform formal DAIR approach to address all 
cases of suspected acute infection as previously 
described in the methods. Although it may be 
controversial, we do not believe in fascia as an 
effective barrier to the progression of bacteria in such 
an early postoperative period. A classic paper by 
Berbari et al. (10) has shown that treatment for a 
(supposedly) superficial infection is an enormous risk 
factor for ultimately developing a PJI with an odds 
ratio of 35.9 (95% confidence interval 8.3 to 154.6). 
Using deep fluid and tissues microbiology 
results to define infection we found that almost all 
patients (38/39) were culture positive in deep 
samples. Although it was not a goal of this paper, we 
have frequently come across cases in which synovial 
fluid presented seemingly innocent features including 
low leukocyte counts despite being culture-positive, 
thus advising caution in interpreting aspiration to rule 
out deep infection and choose superficial 
debridement over a formal DAIR as it has been 
recently suggested (5).  
The overall success rate of DAIR in eradicating 
infection in our cohort was 89.2%. This finding is in 
line with our previously reported 87% success rate in 
treating acute PJI cases (including acute hemato-
genous infections) with the same protocolled 
approach that includes early intervention, systematic 
mobile parts exchange and correct “anti-biofilm” 
antibiotic therapy (11, 12). 
The surgeon´s decision to perform additional 
surgeries in the early postoperative period is based on 
the perceived risk/benefit and often the fear of 
adding morbidity and the lack of obvious clinical 
findings frequently delays proper therapeutic 
intervention. Except for the Enterococcus faecium 
PJI-related death no other major medical or surgical 
complications related to the procedure were noted. 
Although it is open for debate we do not feel this 
complication relating specifically to the DAIR but 
rather an unfortunate event related to the seriousness 
of the infection in a frail patient with major 
comorbidities. 
In addition to immediate complications, we were 
interested in finding out whether the additional 
surgical procedure and delay in rehabilitation would 
have a negative functional impact in the final 
outcome. After excluding patients with unsuccessful 
infection resolution and other unrelated confounding 
factors (ex. periprosthetic fracture) we found that 
infected patients had self-reported equivalent 
functional outcomes to uninfected controls. This 
finding that is also corroborated by other studies (13, 
14), suggests that an early DAIR procedure is a 
“benign” procedure with no significant impact on 
joint function. 
A major limitation of this study relates to the 
methodology of systematically opening the fascia as it 
can be argued that we may have caused bacteria to 
propagate from superficial layers to the joint space 
during the procedure. Nevertheless, we believe that 
our surgical technique of clearly separating deep from 
superficial debridement and sample gathering in the 
rare instances we found the fascia to be 
macroscopically closed is sufficiently careful and 
greatly minimizes this hypothetical risk. Also, the 
criterion used to define infection may be perceived as 
controversial. Still, one must consider that during the 
entire study period there was no universal clear 
definition of PJI in the acute setting. Recently, a PJI 
definition was proposed by the latest ICM consensus 
that also aims to define acute infection (15) but in our 
view, this definition lacks enough evidence and just 
recently it has been shown that the proposed 
thresholds may be missing a large proportion of 
infected cases (16).  
It is our belief that a positive growth in at least 
one appropriately gathered deep sample together 
with an unfavorable clinical course is sufficiently 
specific to assume a PJI diagnosis. Although the 
required prolonged antibiotic therapy after assuming 
a PJI diagnosis is not without inherent complications, 
it is indisputable that missing and infection and 
letting it reach chronicity offers much bigger medical 
and surgical implications. Sendi at al. (17) have also 
shown that adopting a policy for early recognition of 
patients with persistent wound problems and prompt 
surgical treatment with DAIR leads equally high rates 
of success in eradicating the infection.  
Although there is extensive evidence that 
successful total joint arthroplasty greatly increases 
quality of life and joint function, information on the 
impact of PJI are seldomly evaluated using objective 
measurements. Cahill et al. (18) and Helwig et al. (19) 
were able to confirm the negative impact of PJI on 
joint function and health-related quality of life. 
Aboltins et al. (20) prospectively collected data on 
over 2,000 TJA patients, of which PJI occurred in 41. 
Much the same as in our study, PJI cases treated with 
debridement and retention had similar improvements 
as patients without PJI in quality of life according to 
the SF-12 survey. The analysis however did not 
evaluate the potential influence of the infecting 
pathogen. Núñez et al. (21) evaluated 24 patients who 
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underwent debridement and retention of the 
prosthesis due to an acute knee PJI and were in 
remission after 12 months’ follow-up. Health-related 
quality of life was measured using WOMAC and 
SF-36 at baseline, 12 and 24 months after antibiotic 
treatment discontinuation. There was a significant 
improvement in all items from baseline to 48 months 
except for patients infected by Staphylococcus aureus 
who had significantly worse outcomes. In the present 
study, outcomes assessed using joint specific 
patient-reported outcome measures shows similar 
results in DAIR-treated and uneventful control 
patients and no significant differences were found 
according to the type of infecting microorganism. 
Conclusion 
The results of this study seem to support our 
current policy of adopting a low threshold to assume 
a possible infection diagnosis and “aggressively” 
pursuing formal DAIR procedure when facing an 
unfavorable wound healing in the early postoperative 
period after total joint replacement. The results not 
only show it is possible to achieve high success rates 
in treating early infection but also suggests that this 
“aggressive” policy carries no significant impact on 
midterm functional results. As such, we rather risk 
overtreating a small proportion of cases in the acute 
stage than to increase the risk of chronic infection in a 
significant number of patients. 
Although current criteria are still heavily 
punctuated by subjective clinical judgement it seems 
to be highly specific to select truly infected cases. In 
the future, objective criteria must be refined to help 
with decision-making but given the apparently 
“benign” impact of a repeated surgery, one can only 
speculate whether these criteria should evolve to 
become even more comprehensive. 
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